Faking a Cancer Dx? Fallopian Tube Removal; Trodelvy’s New Breast Cancer Indication

A 19-year-old Iowa woman has been arrested after being accused of faking diagnoses of leukemia and pancreatic cancer in order to collect more than $37,000 in online donations. (CBS News)

The Ovarian Cancer Research Alliance is urging even women without high-risk genetic mutations to have their fallopian tubes removed once they’ve finished having children, if they’re undergoing a gynecologic operation anyway. (New York Times)

Cedars-Sinai investigators report they have developed a nanotechnology-based liquid biopsy that can detect and profile prostate cancer, even in microscopic amounts. (Cedars-Sinai, Nano Today)

Prophylaxis with emicizumab (Hemlibra) in the phase III HAVEN 6 trial resulted in effective bleed control and a favorable safety profile in people with mild or moderate hemophilia A without factor VIII inhibitors. (The Lancet Haematology)

Data from 197,000 adults in the U.K. followed over nearly a decade found that risks for cancer and cancer-related death increased the more people added ultra-processed foods to their diet. (eClinicalMedicine)

An artificial intelligence tool called Sybil may be able to predict up to 6 years in advance whether a person will get lung cancer. (Washington Post)

Banana Boat said it’s recalling another batch of its scalp and hair sunscreen spray, expanding on an initial recall last year of three batches that contained trace amounts of the carcinogen benzene.

The FDA approved sacituzumab govitecan (Trodelvy) for unresectable locally advanced or metastatic hormone receptor (HR)-positive, HER2-negative breast cancer in patients who have received endocrine-based therapy and at least two additional systemic therapies in the metastatic setting, Gilead announced.

And Pfizer said the agency expanded its approval of palbociclib (Ibrance) to include combination treatment with an aromatase inhibitor for newly diagnosed HR-positive/HER2-negative metastatic breast cancer regardless of patients’ menopausal status. (Fierce Pharma)

Massage therapy is effective in addressing acute pain, stress, and anxiety among young persons receiving oncology and hematology care, according to a study in Pediatric Blood & Cancer.

MRI is the best supplemental screening modality for women with dense breasts and at average or intermediate risk of breast cancer, a meta-analysis of 22 studies suggested. (Radiology)

Preliminary results from the ongoing phase III STAND trial assessing two dose levels of the sickle cell disease drug crizanlizumab (Adakveo) showed no significant benefit over placebo in annualized rates of vaso-occlusive crises leading to a healthcare visit, said Novartis.